Dergiler / BEYOGLU EYE JOURNAL / 2020 / Cilt: 5 - Sayı: 2

Evaluation of the Long-term Effect of Ethambutol Usage on the Retinal Nerve Fiber Layer Using Spectral-Domain Optical Coherence Tomography

Sayfa
118–121
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

SD-OCT is useful in the follow-up of these patients.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objectives: The aim of this study was to use spectral-domain optical coherence tomography (SD-OCT) to evaluate the long-term effect of ethambutol on the optic nerve fiber layer.
📊
Temel Bulgular & Veri:Methods: Twenty eyes of 10 patients who had been treated with ethambutol for tuberculosis were retrospectively evaluated.
💡
Sonuç & Katkı:SD-OCT is useful in the follow-up of these patients.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Objectives: The aim of this study was to use spectral-domain optical coherence tomography (SD-OCT) to evaluate the long-term effect of ethambutol on the optic nerve fiber layer. Methods: Twenty eyes of 10 patients who had been treated with ethambutol for tuberculosis were retrospectively evaluated. Retinal nerve fiber layer (RNFL) analyses performed initially and about 2 years after the end of treatment were included in the study. Data of visual acuity, fundus examination, other diseases, and drug use history of all of the participants were evaluated. Color vision was tested with the Ishihara Color Test. Superior, inferior, nasal, and temporal quadrant RNFL parameters were evaluated using SD-OCT. Results: The mean age of the 10 patients was 38.77±14.86 years. There were 6 males and 4 females in the group. The mean length of follow-up was 4.44±1.94 months (range: 2-8 months). The mean RNFL result of the analysis performed 2 years after discontinuation of ethambutol treatment was superior RNFL: 122.45±18.64 µ, inferior RNFL: 131.40±13.31 µ, temporal RNFL: 71.60±8.53 µ, and nasal RNFL: 81.70±9.73 µ. There was significant thinning in the temporal quadrant (p<0.05). Conclusion: Long-term use of ethambutol caused thinning in the RNFL. SD-OCT is useful in the follow-up of these patients.

🔖

Bu Makaleye Atıf Yap

VARAN, G., HAZAR, L., SAHİN, A. (2020). Evaluation of the Long-term Effect of Ethambutol Usage on the Retinal Nerve Fiber Layer Using Spectral-Domain Optical Coherence Tomography. BEYOGLU EYE JOURNAL, Cilt: 5 - Sayı: 2, 118–121. https://ajindex.com/articles/164588

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (15)

  1. Etiz P, Altınsu AT. A Retrospective Analysis of 232 Newly Diagnosed Cases with Pulmonary tuberculosis, Türk Mikrobiyol Cem Derg 2018;48:117–24
  2. Sivakumaran P, Harrison AC, Marschner J, Martin P. Ocular toxicity from ethambutol: a review of four cases and recommended precautions. N Z Med J 1998;111:428–30
  3. Kumar A, Sandramouli S, Verma L, Tewari HK, Khosla PK. Ocular ethambutol toxicity: is it reversible?. J Clin Neuroophthalmol 1993;13:15–7
  4. Chai SJ, Foroozan R. Decreased retinal nerve fibre layer thickness detected by optical coherence tomography in patients with ethambutol-induced optic neuropathy. Br J Ophthalmol 2007;91:895–7
  5. Zoumalan CI, Agarwal M, Sadun AA. Optical coherence tomography can measure axonal loss in patients with ethambutolinduced optic neuropathy. Graefes Arch Clin Exp Ophthalmol 2005;243:410–6
  6. Bıçakçı Ş, Özeren A, Yerdelen D, Sarıca Y. Optic Neuropathy Due To Ethambutol Intake: A Case Report. Türkiye Klinikleri J Med Sci 2005;25:460–2
  7. CARR RE, HENKIND P. Ocular manifestations of ethambutol, Toxic amblyopia after administration of an experimental antituberculous drug. Arch Ophthalmol 1962;67:566–71
  8. Leibold JE. The ocular toxicity of ethambutol and its relation to döşe. Ann NY Acad Sci 1966;135:904–9
  9. Chan RY, Kwok AK. Ocular toxicity of ethambutol. Hong Kong Med J 2006;12:56–60
  10. Mudun A. Optical Coherence Tomography in Neuro-Ophthalmological Diseases. ACU Sağlık Bil Derg 2011;2:5–9
  11. Sadun A. Acquired mitochondrial impairment as s cause of optic nerve disease. Trans Am Ophthalmol Soc 1998:881–923
  12. Carelli V, Ross-Cisneros FN, Sadun AA. Optic nerve degeneration and mitochondrial dysfunction: genetic and acquired optic neuropathies. Neurochem Int 2002;40:573–84
  13. Sadun AA. Mitochondrial optic neuropathies. J Neurol Neurosurg Psychiatry 2002;72:423–5
  14. Pavan Taffner BM, Mattos FB, Cunha MCD, Saraiva FP. The use of optical coherence tomography for the detection of ocular toxicity by ethambutol. PLoS One 2018;13:e0204655
  15. Kim U, Hwang JM. Early stage ethambutol optic neuropathy: retinal nerve fiber layer and optical coherence tomography. Eur J Ophthalmol 2009;19:466–9.